Saturday, 15 May 2021 - Program Schedule
*all sessions and times are listed in the Eastern Time Zone (EDT) and subject to change. To assist with how to convert times to your specific time zone; just click here.
08:00 - 09:00 |
Exhibit Hall Open │ Visit and meet with exhibitors |
09:00 - 09:55 |
Pregnancy and Vascular Malformations (What Should We Tell the Patient? and How to Prevent Complications) |
Moderators: Leo Schultze Kool (the Netherlands), Steven Fishman (United States) | |
09:00 - 09:08 |
Pregnancy and Vascular Malformations: What Changes during Pregnancy │ Laura Guirado Manchon (Spain) |
09:08 - 09:18 |
AVM’s during Pregnancy │ Julien Coulie (Belgium) |
09:18 - 09:48 |
Case Presentations with Panel Discussion │ Panelists: Laurence Boon (Belgium), Leonardo Brandão (Canada), Pär Gerwins (Sweden), Gresham Richter (United States), Carine van der Vleuten (the Netherlands), Laura Guirado Manchon (Spain) |
|
09:18 - 09:28 Case 1: KTS and Pregnancy │ Chantal Van der Horst (the Netherlands) |
|
09:28 - 09:38 Case 2: Giant Intrahepatic Venous Malformation with Localized Intravascular Coagulopathy. Follow-up and Treatment during Pregnancy. │ Annouk Bisdorff-Bresson (France) |
|
09:38 - 09:48 Case 3: Large Facial Venous Malformation in a Pregnant Woman │ Jan Jaap Janssen (the Netherlands) |
09:48 - 09:55 |
Wrap-Up Discussion |
09:55 - 10:00 |
Break |
10:00 - 11:25 |
Hemangiomas and Other Vascular Tumors: Challenging Diagnostic or Management Dilemmas |
Moderators: Francine Blei (United States), Joyce Bischoff (United States) | |
10:00 - 10:05 |
Introduction │ Francine Blei (United States) |
10:05 - 10:20 |
Updates from the Ulcerated Hemangioma Multicenter Study │ Esteban Fernandez-Faith (United States) |
10:20 - 10:27 |
Case 1: Widespread Segmental Infantile Haemangioma with Severe Ulceration │Matthew Jones (United Kingdom) |
10:27 - 10:42 |
Basic Science Updates - Propranolol: Mechanism of Action - Some Exciting Insights │ Caroline Seebauer (Germany) |
10:42 - 10:49 |
Case 2: Progressive Infantile Hemangioma Complicated by Poor Response and Poor Tolerance of Beta Blocker │ Magdalena Soldanska (United States) |
10:49 - 11:04 |
What can we Learn from the PHACE Genetic Registry │ Dawn Siegel (United States) |
11:04 - 11:19 |
The Hemangioma Referral Score - A Handy Tool │ Lisa Weibel (Switzerland) |
11:19 - 11:25 |
Discussion |
11:25 - 11:30 |
Break |
11:30 - 12:55 |
Complicated Lymphatic Anomalies (CLA) from Bench to Bedside and Back! |
Moderators: Denise Adams (United States), Gulraiz Chaudry (United States) | |
11:30 - 11:50 |
A Clinical overview of Complicated Lymphatic Anomalies: Clinical Pearls of Diagnosis and Treatment │ Gulraiz Chaudry (United States) |
11:50 - 12:35 |
Case Presentations with Panel Discussion │ Panelists: Juan Carlos Lopez-Gutierrez: (Spain), Jochen Rössler (Switzerland), Maxim Itkin (United States) |
|
11:50 - 12:05 Case 1: Generalized Lymphatic Anomaly (GLA) or Gorham Stout Disease (GSD) - Successful Treatment of Chylothorax in Gorham-Stout Disease using Percutaneous Lymphatic Embolization │ Michael Fox (United States) - Generalized Lymphatic Anomaly │ Janna Vassantachart (United States) |
|
12:05 - 12:20 Case 2: Kaposiform Lymphangiomatosis (KLA) - Severe KLA Treated with MEK Inhibition │ Guy Chowers (Israel) - Chylopericardium Management in CLA Patients │ Paloma Triana (Spain) |
|
12:20 - 12:35 Case 3: Central Conducting Lymphatic Anomaly (CCLA) - Central Conducting Channel Anomaly Presenting with Rectovaginal Leak and Abdominal Pain │ Abhay Srinivasan (United States) - Cervicofacial Lymphatic Malformation with Chylothorax │ Sara Smith (United States) |
12:35 - 12:55 |
Recent Advances in Research on Complicated Lymphatic Anomalies │ Michael Dellinger (United States) |
12:55 - 13:00 |
Closing Remarks │ Tony Penington (Australia) |